NCT05305456View on ClinicalTrials.gov

Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

June 2, 2022

Study Completion Date

August 31, 2022

Conditions
Novel Coronavirus Pneumonia
Interventions
DRUG

Tanreqing capsule

3 capsules per time, 3 times a day

DRUG

Tanreqing capsule simulator

3 capsules per time, 3 times a day

Trial Locations (2)

200040

Huashan Hospital Affiliated to Fudan University, Shanghai

200093

Shanghai Public Health Clinical Center, Shanghai

All Listed Sponsors
collaborator

Ruijin Hospital

OTHER

lead

Jiangsu Famous Medical Technology Co., Ltd.

INDUSTRY